EP0239607A1 - Regulation de la croissance des tissus - Google Patents

Regulation de la croissance des tissus

Info

Publication number
EP0239607A1
EP0239607A1 EP86905906A EP86905906A EP0239607A1 EP 0239607 A1 EP0239607 A1 EP 0239607A1 EP 86905906 A EP86905906 A EP 86905906A EP 86905906 A EP86905906 A EP 86905906A EP 0239607 A1 EP0239607 A1 EP 0239607A1
Authority
EP
European Patent Office
Prior art keywords
solution
biotin
preparation
temperature
tissue growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP86905906A
Other languages
German (de)
English (en)
Inventor
Neil Geddes Clarkson Hendry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP0239607A1 publication Critical patent/EP0239607A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Préparation de régulation de la croissance des tissus comprenant (a) au moins un élément parmi une N-acétyle-D-glycosamine ou un de ses oligomères ou un de ses dérivés désacétylés ou un produit substitué de ces composés, (b) au moins un élément parmi la biotine ou un analogue ou dérivé de biotine ou un de ses résidus biologiquement actifs, et (c) un cation métallique bivalent combiné à un anion pharmaceutiquement acceptable.
EP86905906A 1985-10-08 1986-10-08 Regulation de la croissance des tissus Withdrawn EP0239607A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858524807A GB8524807D0 (en) 1985-10-08 1985-10-08 Tissue growth regulation
GB8524807 1985-10-08

Publications (1)

Publication Number Publication Date
EP0239607A1 true EP0239607A1 (fr) 1987-10-07

Family

ID=10586368

Family Applications (1)

Application Number Title Priority Date Filing Date
EP86905906A Withdrawn EP0239607A1 (fr) 1985-10-08 1986-10-08 Regulation de la croissance des tissus

Country Status (10)

Country Link
EP (1) EP0239607A1 (fr)
JP (1) JPS63501077A (fr)
AU (1) AU606038B2 (fr)
CA (1) CA1289885C (fr)
CS (1) CS265224B2 (fr)
DD (1) DD272034A5 (fr)
GB (1) GB8524807D0 (fr)
IN (1) IN168295B (fr)
WO (1) WO1987002244A1 (fr)
ZA (1) ZA867664B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5273900A (en) * 1987-04-28 1993-12-28 The Regents Of The University Of California Method and apparatus for preparing composite skin replacement
CA1318592C (fr) * 1988-11-18 1993-06-01 University Of British Columbia N-acetylglucosamine, agent cytoprotecteur
US5229374A (en) * 1992-01-28 1993-07-20 Burton Albert F Method for treatment of lower gastrointestinal tract disorders
US5192750A (en) * 1992-01-28 1993-03-09 The University Of British Columbia Method and composition for treatment of food allergy
US5217962A (en) * 1992-01-28 1993-06-08 Burton Albert F Method and composition for treating psoriasis
US6046179A (en) * 1998-04-17 2000-04-04 Murch; Simon Composition for and treatment of inflammatory bowel disease by colon administration of N-acetylglucosamine
US6159485A (en) 1999-01-08 2000-12-12 Yugenic Limited Partnership N-acetyl aldosamines, n-acetylamino acids and related n-acetyl compounds and their topical use
CN1173706C (zh) 2001-02-28 2004-11-03 中国人民解放军第三军医大学 N-乙酰-d-氨基葡萄糖在制备治疗宫颈糜烂药物中的应用
CN1199645C (zh) 2002-08-13 2005-05-04 中国人民解放军第三军医大学 N－乙酰－d－氨基葡萄糖在制备治疗泌尿生殖道感染药物中的应用
EP1666046A4 (fr) * 2003-09-17 2007-10-03 Univ Pla 3Rd Military Medical Utilisation de la n-acetyl-d-aminoglycosamine pour la preparation de medicaments de traitement du cancer et des metastases
JP4496375B2 (ja) * 2004-05-21 2010-07-07 国立大学法人鳥取大学 創傷の治療又は処置のための薬剤
ITBS20070178A1 (it) * 2007-11-15 2009-05-16 Paoli Ambrosi Gianfranco De Composizione per uso farmaceutico e/o cosmetico e/o in forma di dispositivo medico per favorire processi di cicatrizzazione, per il trattamento di cicatrici ipertrofiche e per migliorare le proprieta' biomeccaniche della cute

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3232836A (en) * 1959-08-24 1966-02-01 Pfizer & Co C Facilitating healing of body surface wounds by intravenous administration of n-acetyl glucosamine, glucosamine, or pharmaceutically acceptable acid salts of glucosamine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO8702244A1 *

Also Published As

Publication number Publication date
AU6409486A (en) 1987-05-05
IN168295B (fr) 1991-03-09
JPS63501077A (ja) 1988-04-21
WO1987002244A1 (fr) 1987-04-23
AU606038B2 (en) 1991-01-31
CS265224B2 (en) 1989-10-13
CS729286A2 (en) 1989-01-12
CA1289885C (fr) 1991-10-01
DD272034A5 (de) 1989-09-27
ZA867664B (en) 1987-05-27
GB8524807D0 (en) 1985-11-13

Similar Documents

Publication Publication Date Title
US4707471A (en) Water-soluble aminated β-1,3-bound D-glucan and composition containing same
US4760051A (en) Use of GHL-Cu as a wound-healing and anti-inflammatory agent
EP0239607A1 (fr) Regulation de la croissance des tissus
KR100332250B1 (ko) 2',5'-올리고아데닐레이트2',3'-시클로포스페이트
GB2208602A (en) Dried earthworm powder
Johnson Biological acetylation of isoniazid
JPS6152125B2 (fr)
US4330527A (en) Wound treatment agent
WO1992002231A1 (fr) Agent anti-vih
JPH0427964B2 (fr)
CZ293353B6 (cs) Farmaceutický prostředek pro prevenci nebo léčení poruchy růstu vlasů
Pouillart et al. Trial of BCG immunotherapy in the treatment of resectable squamous cell carcinoma of the bronchus (stages I and II)
US6992073B2 (en) Use of N-acetyl-D-glucosamine in the manufacture of a medicament for treating cervical erosion
Hagemann Effect of dimethyl sulfoxide on RNA synthesis in S-180 tumor cells
Seegmiller et al. Excessive uric acid production in the human induced by 2-ethylamino-1, 3, 4-thiadiazole
US5849783A (en) Autobiotics and their use in eliminating nonself cells
JP3040711B2 (ja) 抗腫瘍剤及びその製造法
KR960011231B1 (ko) 인체 백혈구 인터페론 및 침투 향상제를 함유하는 피부 병변 치료용 국소 조성물
RU2314814C2 (ru) Ксеногенные олиго- или/и полирибонуклеотиды в качестве средств для лечения злокачественных опухолей
JP2003508442A (ja) 外因性オリゴリボヌクレオチドおよび／またはポリリボヌクレオチドを含有する医薬品
Tamm et al. Specific requirements for the action of deoxyribonuclease
RU2235550C2 (ru) Лекарственное средство бионормализующего действия и способ его получения
JPH04187640A (ja) 経口・経皮免疫機能促進剤、動物用経口・経皮免疫機能促進剤
JP2889491B2 (ja) 血圧降下剤
RU2144826C1 (ru) Способ получения тканевого препарата для лечения заболеваний желудочно-кишечного тракта

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

17P Request for examination filed

Effective date: 19871015

17Q First examination report despatched

Effective date: 19890531

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 19920222